Please try another search
Breaking News
SYN-TECH Chem. & Pharm. Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 269.78 million compared to TWD 267.28 million a year ago. Net income was TWD 87.38 million compared to TWD 65.52 million a year ago. Basic earnings per share from continuing operations was TWD 1.96 compared to TWD 1.47 a year ago. Diluted earnings per share from continuing operations was TWD 1.96 compared to TWD 1.47 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 271.89 | 330.37 | 245.14 | |
Gross Profit | 95.51 | 113.48 | 89.81 | |
Operating Income | 61.65 | 80.06 | 59.02 | |
Net Income | 25.47 | 92.48 | 67.54 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 2900.89 | 2967.44 | 2903.63 | |
Total Liabilities | 583.48 | 676.3 | 705.02 | |
Total Equity | 2317.41 | 2291.14 | 2198.61 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 74.24 | 96.41 | 51.81 | |
Cash From Investing Activities | -78.63 | -118.04 | -93.8 | |
Cash From Financing Activities | -100.37 | -84.84 | -46.08 | 4.6 |
Net Change in Cash | -78.15 | -89.23 | -67.71 | -37.39 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review